Recombinant Human Anti-OPN x Human Anti-VEGF Bispecific Antibody (IgG-Fv) (BSGV-H347)

Recombinant Anti-OPN x Anti-VEGF Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-OPN antibody variable domain is fused to the C terminal of an IgG of anti-VEGF antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can bind two factors simultaneously. It is designed for the research of Hepatocellular cancer; Metastatic cancer therapy.

Datasheet INQUIRY

Specifications

Targets

OPN & VEGF

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Hepatocellular cancer; Metastatic cancer

Targets

Target 1

OPN

Gene ID

6696

UniProt ID

A0A024RDE6

Alternative Names

OPN; BNSP; BSPI; ETA-1; Osteopontin; bone sialoprotein I; BSP-1; SPP1; secreted phosphoprotein 1

Target 2

VEGF

Gene ID

7422

UniProt ID

P15692

Alternative Names

VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-OPN x Human Anti-VEGF Bispecific Antibody (IgG-Fv) (BSGV-H347). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-OPN x Human Anti-VEGF Bispecific Antibody (IgG-Fv) (CAT#: BSGV-H347)

Specifications

Targets

Customer Reviews and Q&As